U.S. flag

An official website of the Department of Health & Human Services

AHRQ: Agency for Healthcare Research and Quality

Substance Use Tools & Resources   

Read the Guide

This collection of tools and resources is for providers, staff, and patients who offer or use services to address substance use, and other interested stakeholders. This collection was originally established following an environmental scan on implementing medication-assisted treatment (MAT) for opioid use disorder (OUD) in rural primary care. (See PDFs of Volume 1 [PDF 0.69 MB] and Volume 2 [PDF 1.28 MB] of that scan). Items have been continuously added to this collection since then, and the collection has expanded to cover substance use more broadly, rather than just MAT for OUD.

Displaying 21 - 30 of 84

2022 National Drug Control Strategy

This inaugural National Strategy proposes bold, targeted, and consequential actions to bend the curve on overdose deaths in the immediate term and reduce substance use and its damaging consequences in the US over the longer term.

Format
Guide
Report/Paper/Issue Brief
Audience
Behavioral Health Providers
Communities
Medical Providers
Other Team Members
Policymakers and Payers
Source
The White House Executive Office of the President, Office of National Drug Control Policy (ONDCP)
Year
Resource Type
PDF
File Size
2.6 MB

College-Age & Young Adults and Substance Use

This NIDA web page incudes resources for students, parents, educators, dorm supervisors, counselors, clinicians, and researchers related to substance use in college-age adults ages 19 to 22.
Format
Web Page
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Patients
Families
Communities
Schools
Graduate Education
Source
National Institute on Drug Abuse (NIDA)
Year
Resource Type
Web Page

Fentanyl Drug Checking and Screening: Roundtable on Clinical Perspectives Summary Report

This document summarizes the discussion from the meeting of clinicians and researchers who are knowledgeable about screening for fentanyl and other drugs, primarily in health care settings. The focus of the meeting was to understand clinician/researcher perspectives about clinical fentanyl testing and distribution of fentanyl test strips (FTS) to patients and discuss next steps for technology development, research, and practice.
Format
Report/Paper/Issue Brief
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Source
Reagan-Udall Foundation for the FDA (Food and Drug Administration)
Year
Resource Type
PDF
File Size
562 KB

Fentanyl Drug Checking and Screening: Roundtable on Community Perspectives Summary Report

These proceedings summarize the discussion from the harm reduction community roundtable and supplemental individual interviews, inclusive of representatives from national and local harm reduction organizations, state and local government agencies, tribal organizations, and researchers who have experience distributing fentanyl test strips (FTS) or are knowledgeable about FTS specifically or drug checking more generally.

Format
Report/Paper/Issue Brief
Audience
Behavioral Health Providers
Communities
Medical Providers
Other Team Members
Source
Reagan-Udall Foundation for the FDA (Food and Drug Administration)
Year
Resource Type
PDF
File Size
593 KB

Food and Drug Administration Overdose Prevention Framework

The FDA Overdose Prevention Framework consists of four overarching priorities that align with the U.S. Department of Health & Human Services' Overdose Prevention Strategy to address the public health emergency as it continues to evolve.
Format
Toolkit
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Source
Food and Drug Administration (FDA)
Year
Resource Type
PDF
File Size
146 KB